Sector: Pharmaceuticals & Biotechnology

Small Cap

Syncom Formulation Share Price

Syncom Formulation (India) Ltd.

₹15.56

-0.44(-2.75%)

Trade Now

27th May 2026 | 3:28 PM

NSE : SYNCOMF

Open Free Demat Account

Syncom Formulation Performance

Price Movement

₹15.56

₹15.51

₹16.40

↘ Today's Low↗ Today's High

1 Year Performance

₹15.56

₹10.21

₹23.49

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹16.40

Low₹15.51

Open at₹16.04

Prev Close₹16.00

Volumes39.09 L

Avg Price₹15.86

Lower Circuit₹12.80

Upper Circuit₹19.20

Historical Performance

3M High₹16.56

3M Low₹10.21

1 Yr High₹23.49

1 Yr Low₹10.21

3 Yr High₹27.90

3 Yr Low₹6.30

5 Yr High₹27.90

5 Yr Low₹4.60

Syncom Formulation Fundamentals

Market Cap

Above industry Median

1,466.40 Cr.

PE Ratio (TTM)

Below industry Median

19.20

Dividend Yield

Net Profit TTM

54.6% incr over last year

76.44

Net Profit Growth

54.6% incr over last year

76.44

PEG Ratio

Below industry Median

0.40

ROE

27.5% incr over last year

18.41

Operating Revenue TTM

489.17

Operating Revenue Growth

5.0% incr over last year

Book Value

Above industry Median

3.70

MFI

MFI strongly Overbought

86.09

RSI

RSI Overbought

73.38

EPS (TTM)

0.81

Debt to Equity

Face Value

Operating Profit Margin Qtr.

14.88

Operating Profit Qtr.

22.01

Net Profit Qtr.

25.17

Operating Revenue Qtr.

135.41

PB Ratio

3.70

Syncom Formulation Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	134	114.59	121.44	116.55	148.46
Operating Expense	112.51	93.42	102.71	100.77	130.99
Operating Profit	21.49	21.17	18.72	15.77	17.47
Depreciation	2.48	1.36	1.35	1.34	1.29
Interest	0.37	0.25	0.25	0.24	0.09
Tax	8.29	6.18	5.52	4.53	5.51
Net Profit	24.57	18.86	16.84	15.73	17.50

Syncom Formulation Technicals

Syncom Formulation (India) Ltd. EMA & SMA

₹15.56

-0.44 (-2.75%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹15.2

Day EMA10 ₹14.7

Day EMA12 ₹14.6

Day EMA20 ₹14.3

Day EMA26 ₹14.1

Day EMA50 ₹13.7

Day EMA100 ₹13.8

Day EMA200 ₹14.6

Syncom Formulation Support and Resistance

Resistance

First Resistance₹16.29

Second Resistance₹16.59

Third Resistance₹16.78

Support

First Support₹15.80

Second Support₹15.61

Third Support₹15.31

Technical Indicators

Day RSI73.38

Day MFI86.09

Day ADX21.24

Day Commodity Channel Index262.60

William-16.72

Day MACD0.48

Day MACD Signal Line0.34

Day ATR0.69

Day ROC125-

Day ROC2118.78

Syncom Formulation Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	50.6	50.6	50.6	50.6	50.6	50.6
FII	0.1	0.1	0.4	0.1	0.3	0.2
DII	0	0	0	0	0	0
Public	49.3	49.3	49	49.3	49.2	49.2

Syncom Formulation Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	22.12 L	57.73 L	38.32%
Week	22.43 L	79.04 L	28.38%
1 Month	13.68 L	35.31 L	38.74%
6 Month	10.56 L	21.81 L	48.41%

Syncom Formulation SWOT Analysis

Strengths29

Weakness3

Opportunity0

Threats0

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Companies with 10% increase in share price over three months, with rising net profit growth

Undervalued Growth Stocks

Strong Momentum: Price above short, medium and long term moving averages

Jim Slater's Zulu Principle (Discover Growth Stocks)

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing profits every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Syncom Formulation Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Instrument Type
09 Sep, 2022	0.03	FINAL	Equity Share
21 Sep, 2017	0.02	FINAL	Equity Share
22 Sep, 2016	0.02	FINAL	Equity Share
16 Sep, 2015	0.02	FINAL	Equity Share
18 Sep, 2014	0.02	FINAL	Equity Share
10 Jul, 2013	0.6	FINAL	Equity Share
20 Sep, 2012	0.6	FINAL	Equity Share
22 Sep, 2011	0.5	FINAL	Equity Share
23 Sep, 2010	0.5	FINAL	Equity Share
24 Sep, 2009	0.5	FINAL	Equity Share

Syncom Formulation Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Innova Captab Ltd.
Price (₹)	₹486.75	₹6.46	₹132.26	₹14.29	₹563.80	₹844
% Change	0.64%	0.00%	-0.74%	1.71%	1.08%	0.06%
Revenue TTM (₹ Cr)	-	₹83.60	₹287.68	-	₹502.55	₹1,630.02
Net Profit TTM (₹ Cr)	-	₹-34.95	₹14.88	-	₹57.92	₹140.92
PE TTM	-	-1.50	34.40	-	28.00	34.40
1 Year Return	23.66	545	4.6	56.59	-22.32	-2.92
ROCE	3.56	-5.63	-	-	23.87	15.27

Similar Stocks

VALIANTLAB

Valiant Laboratories Ltd.

₹ 80.00

+1.60%

SIGACHI

Sigachi Industries Ltd.

₹ 20.57

+1.33%

WINDLAS

Windlas Biotech Ltd.

₹ 821.00

-0.22%

VINEETLAB

Vineet Laboratories Ltd.

₹ 35.00

+0.43%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 544.00

-2.60%

ZIMLAB

Zim Laboratories Ltd.

₹ 102.60

-0.77%

MEDICO

Medico Remedies Ltd.

₹ 49.00

+1.51%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 197.52

-1.50%

LASA

Lasa Supergenerics Ltd.

₹ 8.63

+4.99%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 372.20

-1.22%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 311.50

+2.05%

ORTINGLOBE

Ortin Global Ltd.

₹ 16.31

+4.95%

BROOKS

Brooks Laboratories Ltd.

₹ 62.19

+5.00%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2239.00

+1.14%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 129.90

-0.20%

ALPA

Alpa Laboratories Ltd.

₹ 71.15

+0.66%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 378.90

+0.70%

NECLIFE

Nectar Lifesciences Ltd.

₹ 12.41

+1.14%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 28.70

-0.66%

INDOCO

Indoco Remedies Ltd.

₹ 203.00

+5.11%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 134.90

-0.93%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 760.00

+1.68%

PANACEABIO

Panacea Biotec Ltd.

₹ 413.50

-2.49%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 284.95

+4.65%

FAQ's on SYNCOMF

What is the current share price of Syncom Formulation (India) Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Syncom Formulation (India) Ltd. is ₹ 15.56 on the NSE and ₹ 15.58 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Syncom Formulation (India) Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Syncom Formulation (India) Ltd. is approximately ₹ 1466.4 Cr.

What are the PE and PB ratios for Syncom Formulation (India) Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Syncom Formulation (India) Ltd. is 19.2, and the Price-to-Book (PB) ratio is 3.7.

What is the 52-Week High and Low for Syncom Formulation (India) Ltd.?

Over the past 52 weeks, the highest price reached by Syncom Formulation (India) Ltd. shares was ₹ 23.49, and the lowest price was ₹ 10.21.

Who are the major shareholders of Syncom Formulation (India) Ltd.?

Significant shareholdings in Syncom Formulation (India) Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Syncom Formulation (India) Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Syncom Formulation (India) Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for Syncom Formulation (India) Ltd.?

Syncom Formulation (India) Ltd. last declared a FINAL dividend of ₹ 0.03 per share for the financial period ending 2022. The record date was set as 2022-09-09, and the payment was/is scheduled around 2022-09-09. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy